It is important to note that almost all T98G cells express TRAIL-R2 at the baseline and Olaparib treatment altered the level of expression on the cell surface, thus potentially strengthening the activation signal to GBM tumour-infiltrating NK cells. The gene discussed is TNFRSF10B; the disease is neoplasm.